http://healthcarefirms.com The Healthcare Industry Website Directory - Coming Soon Sat, 05 Feb 2011 02:14:44 +0000 en hourly 1 http://wordpress.org/?v=3.2.1 http://healthcarefirms.com/map-pharmaceuticals-inc/ http://healthcarefirms.com/map-pharmaceuticals-inc/#comments Tue, 02 Mar 2010 18:40:16 +0000 admin MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of its Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

]]> http://healthcarefirms.com/map-pharmaceuticals-inc/feed/ 0 http://healthcarefirms.com/Emisphere-Technologies-Inc/ http://healthcarefirms.com/Emisphere-Technologies-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Emisphere is a biopharmaceutical company that focuses on a unique and improved delivery of pharmaceutical compounds and nutritional supplements using its Eligen(R) Technology. These molecules and compounds could be currently available or in development. Such molecules are usually delivered by injection; in many cases, their benefits are limited due to poor bioavailability, slow on-set of action or variable absorption. The Eligen(R) Technology can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal.

]]> http://healthcarefirms.com/Emisphere-Technologies-Inc/feed/ 0 http://healthcarefirms.com/Flamel-Technologies-SA/ http://healthcarefirms.com/Flamel-Technologies-SA/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Flamel Technologies, S.A. is a biopharmaceutical company principally engaged in the development of two unique polymer-based delivery technologies for medical applications.

]]> http://healthcarefirms.com/Flamel-Technologies-SA/feed/ 0 http://healthcarefirms.com/Generex-Biotechnology-Corp/ http://healthcarefirms.com/Generex-Biotechnology-Corp/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The company

]]> http://healthcarefirms.com/Generex-Biotechnology-Corp/feed/ 0 http://healthcarefirms.com/Hospira-Inc/ http://healthcarefirms.com/Hospira-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care.

]]> http://healthcarefirms.com/Hospira-Inc/feed/ 0 http://healthcarefirms.com/Insite-Vision-Inc/ http://healthcarefirms.com/Insite-Vision-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin InSite Vision develops novel ophthalmic products designed to treat a growing range of common eye problems, including ocular infection, glaucoma, and retinal disease. Insite Vision’s goal is to provide patients and physicians with improved treatment options that help preserve and improve vision worldwide.

]]> http://healthcarefirms.com/Insite-Vision-Inc/feed/ 0 http://healthcarefirms.com/Matrixx-Initiatives-Inc/ http://healthcarefirms.com/Matrixx-Initiatives-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Matrixx Initiatives, Inc. is engaged in the development and marketing of over-the-counter healthcare products that utilize innovative drug delivery systems. Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam(R) products in the cough and cold category. The Company markets Zicam brand pharmaceuticals, including Zicam Cold Remedy in multiple oral delivery forms; Zicam Allergy and Congestion Relief products; as well as Zicam Cough and Zicam Multi-Symptom relief items.

]]> http://healthcarefirms.com/Matrixx-Initiatives-Inc/feed/ 0 http://healthcarefirms.com/Nektar-Therapeutics/ http://healthcarefirms.com/Nektar-Therapeutics/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its PEGylation and advanced polymer conjugation technology platforms. Nektar’s technology and drug development expertise have enabled nine approved products in the U.S. or Europe for leading biopharmaceutical company partners, including UCB’s Cimzia(R) for Crohn’s disease and rheumatoid arthritis, Roche’s PEGASYS(R) for hepatitis C and Amgen’s Neulasta(R) for neutropenia. Nektar has created a robust pipeline of potentially high-value therapeutics to address unmet medical needs by leveraging and expanding its technology platforms to improve and enable molecules. Nektar is currently conducting clinical and preclinical programs in oncology, pain and other therapeutic areas. Nektar recently entered into an exclusive worldwide license agreement with AstraZeneca for its oral NKTR-118 program to treat opioid-induced constipation and its NKTR-119 program for the treatment of pain without constipation side effects. NKTR-102 is being evaluated in Phase 2 clinical studies for the treatment of ovarian, breast and colorectal cancers. NKTR-105 is in a Phase 1 clinical study in cancer patients with refractory solid tumors.

]]> http://healthcarefirms.com/Nektar-Therapeutics/feed/ 0 http://healthcarefirms.com/Novadel-Pharma-Inc/ http://healthcarefirms.com/Novadel-Pharma-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin NovaDel Pharma Inc. is a specialty pharmaceutical company developing oral spray formulations of a broad range of marketed therapeutics.

]]> http://healthcarefirms.com/Novadel-Pharma-Inc/feed/ 0 http://healthcarefirms.com/Penwest-Pharmaceuticals-Co/ http://healthcarefirms.com/Penwest-Pharmaceuticals-Co/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Penwest is a drug development company focused on identifying and developing products that address unmet medical needs, primarily for rare disorders of the nervous system. Penwest is currently developing A0001, or a-tocopherolquinone, a coenzyme Q10 analog demonstrated to improve mitochondrial function in-vitro. Penwest is also applying its drug delivery technologies and drug formulation expertise to the formulation of our collaborators’ product candidates under licensing collaborations.

]]> http://healthcarefirms.com/Penwest-Pharmaceuticals-Co/feed/ 0 http://healthcarefirms.com/pSivida-Corp/ http://healthcarefirms.com/pSivida-Corp/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin pSivida is a world leader in the development of tiny, sustained release, drug delivery products that are administered by implantation, injection or insertion. pSivida’s lead development product delivers fluocinolone acetonide (FA) for the treatment of diabetic macular edema. pSivida’s intellectual property portfolio consists of 62 patent families, over 100 granted patents, including patents accepted for issuance, and over 200 patent applications. pSivida conducts its operations from Boston in the United States and Malvern in the United Kingdom.

]]> http://healthcarefirms.com/pSivida-Corp/feed/ 0 http://healthcarefirms.com/Symbollon-Pharmaceuticals-Inc/ http://healthcarefirms.com/Symbollon-Pharmaceuticals-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin About Symbollon Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products based on its molecular iodine technology for women

]]> http://healthcarefirms.com/Symbollon-Pharmaceuticals-Inc/feed/ 0 http://healthcarefirms.com/The-Quigley-Corporation/ http://healthcarefirms.com/The-Quigley-Corporation/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin The Quigley Corporation is a diversified natural health medical science company. Quigley’s Cold Remedy segment is a leading marketer and manufacturer of the Cold-EEZE

]]> http://healthcarefirms.com/The-Quigley-Corporation/feed/ 0 http://healthcarefirms.com/ULURU-Inc/ http://healthcarefirms.com/ULURU-Inc/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex

]]> http://healthcarefirms.com/ULURU-Inc/feed/ 0 http://healthcarefirms.com/Cellegy-Pharmaceuticals-/ http://healthcarefirms.com/Cellegy-Pharmaceuticals-/#comments Thu, 25 Feb 2010 23:54:10 +0000 admin Cellegy Pharmaceuticals is a specialty biopharmaceutical company that specializes in women’s health. Savvy(R) (C31G vaginal gel), a microbicide gel product for contraception, is currently undergoing Phase 3 clinical studies in the United States for contraception.

]]> http://healthcarefirms.com/Cellegy-Pharmaceuticals-/feed/ 0 http://healthcarefirms.com/Acura-Pharmaceuticals-Inc/ http://healthcarefirms.com/Acura-Pharmaceuticals-Inc/#comments Thu, 25 Feb 2010 23:54:09 +0000 admin Acura Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in research, development and manufacture of innovative Aversion

]]> http://healthcarefirms.com/Acura-Pharmaceuticals-Inc/feed/ 0 http://healthcarefirms.com/Alkermes-Inc/ http://healthcarefirms.com/Alkermes-Inc/#comments Thu, 25 Feb 2010 23:54:09 +0000 admin Alkermes, Inc. is a fully integrated biotechnology company committed to developing innovative medicines to improve patients’ lives. Alkermes’ robust pipeline includes extended-release injectable, pulmonary and oral products for the treatment of prevalent, chronic diseases, such as central nervous system disorders, addiction and diabetes. Headquartered in Waltham, Massachusetts, Alkermes has a research facility in Massachusetts and a commercial manufacturing facility in Ohio.

]]> http://healthcarefirms.com/Alkermes-Inc/feed/ 0 http://healthcarefirms.com/Aradigm-Corp/ http://healthcarefirms.com/Aradigm-Corp/#comments Thu, 25 Feb 2010 23:54:09 +0000 admin Aradigm is an emerging specialty pharmaceutical company developing and commercializing a portfolio of drugs delivered by inhalation for the treatment of severe respiratory disease.

]]> http://healthcarefirms.com/Aradigm-Corp/feed/ 0 http://healthcarefirms.com/Biopath-Holdings-Inc/ http://healthcarefirms.com/Biopath-Holdings-Inc/#comments Thu, 25 Feb 2010 23:54:09 +0000 admin Bio-Path Holdings, Inc. is developing leading edge, patented, liposomal drug delivery systems. It haS two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path

]]> http://healthcarefirms.com/Biopath-Holdings-Inc/feed/ 0 http://healthcarefirms.com/Biovail-Corporation/ http://healthcarefirms.com/Biovail-Corporation/#comments Thu, 25 Feb 2010 23:53:12 +0000 admin Biovail Corporation is a pioneer and world leader in the development, manufacture and marketing of controlled-release pharmaceutical products.

]]> http://healthcarefirms.com/Biovail-Corporation/feed/ 0 http://healthcarefirms.com/Columbia-Laboratories-Inc/ http://healthcarefirms.com/Columbia-Laboratories-Inc/#comments Thu, 25 Feb 2010 23:53:12 +0000 admin Columbia Laboratories, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the women

]]> http://healthcarefirms.com/Columbia-Laboratories-Inc/feed/ 0 http://healthcarefirms.com/Elan-Corp-plc/ http://healthcarefirms.com/Elan-Corp-plc/#comments Thu, 25 Feb 2010 23:53:12 +0000 admin Elan Drug Technologies a leading drug delivery company is a business unit of Elan Corporation, plc. Elan developed the sustained release formulation of dalfampridine, using one of its Oral Controlled Release Technologies, the MXDAS(TM) (MatriX Drug Absorption System) technology. Elan Drug Technologies offers clients drug delivery expertise with a suite of commercially launched, proprietary, technology-driven solutions, from NanoCrystal(R) technology for poorly water soluble compounds, to customised oral controlled release drug technologies. Elan aims to deliver clinically meaningful benefits to patients by using its extensive experience and proprietary delivery technologies in collaboration with pharmaceutical companies. Products enabled by EDT technologies are used by millions of patients each day.

]]> http://healthcarefirms.com/Elan-Corp-plc/feed/ 0 http://healthcarefirms.com/delcath-systems-inc/ http://healthcarefirms.com/delcath-systems-inc/#comments Fri, 26 Feb 2010 07:37:08 +0000 admin http://healthcarefirms.com/?p=1189 Delcath Systems, Inc. is a medical technology company specializing in cancer treatment. The Company is testing a proprietary, patented drug delivery system for the treatment of primary and metastatic liver cancers. Delcath’s novel drug delivery platform is testing the delivery of ultra-high doses of anti-cancer agents to the liver while controlling the systemic exposure of those agents.  In addition to its fully enrolled Phase III metastatic melanoma study, the Company is currently conducting trials to treat other forms of tumor metastases to the liver. The Company maintains a broad intellectual property portfolio on a worldwide basis including the U.S., Europe, Asia and Canada.

]]> http://healthcarefirms.com/delcath-systems-inc/feed/ 0 http://healthcarefirms.com/igi-laboratories-inc/ http://healthcarefirms.com/igi-laboratories-inc/#comments Wed, 17 Feb 2010 12:38:22 +0000 admin IGI Laboratories, Inc. engages in the development, manufacturing, filling, and packaging of topical, semi solid, and liquid products for pharmaceutical and cosmeceutical companies. The Company offers the patented Novasome

]]> http://healthcarefirms.com/igi-laboratories-inc/feed/ 0 http://healthcarefirms.com/halozyme-therapeutics-inc/ http://healthcarefirms.com/halozyme-therapeutics-inc/#comments Wed, 17 Feb 2010 09:33:00 +0000 admin Halozyme Therapeutics is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. The company’s portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix.

]]> http://healthcarefirms.com/halozyme-therapeutics-inc/feed/ 0